Literature DB >> 28000146

Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Cecilia J Sorensen1, Kristen DeSanto2, Laura Borgelt3, Kristina T Phillips4, Andrew A Monte5,6,7.   

Abstract

Cannabinoid hyperemesis syndrome (CHS) is a syndrome of cyclic vomiting associated with cannabis use. Our objective is to summarize the available evidence on CHS diagnosis, pathophysiology, and treatment. We performed a systematic review using MEDLINE, Ovid MEDLINE, Embase, Web of Science, and the Cochrane Library from January 2000 through September 24, 2015. Articles eligible for inclusion were evaluated using the Grading and Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Data were abstracted from the articles and case reports and were combined in a cumulative synthesis. The frequency of identified diagnostic characteristics was calculated from the cumulative synthesis and evidence for pathophysiologic hypothesis as well as treatment options were evaluated using the GRADE criteria. The systematic search returned 2178 articles. After duplicates were removed, 1253 abstracts were reviewed and 183 were included. Fourteen diagnostic characteristics were identified, and the frequency of major characteristics was as follows: history of regular cannabis for any duration of time (100%), cyclic nausea and vomiting (100%), resolution of symptoms after stopping cannabis (96.8%), compulsive hot baths with symptom relief (92.3%), male predominance (72.9%), abdominal pain (85.1%), and at least weekly cannabis use (97.4%). The pathophysiology of CHS remains unclear with a dearth of research dedicated to investigating its underlying mechanism. Supportive care with intravenous fluids, dopamine antagonists, topical capsaicin cream, and avoidance of narcotic medications has shown some benefit in the acute setting. Cannabis cessation appears to be the best treatment. CHS is a cyclic vomiting syndrome, preceded by daily to weekly cannabis use, usually accompanied by symptom improvement with hot bathing, and resolution with cessation of cannabis. The pathophysiology underlying CHS is unclear. Cannabis cessation appears to be the best treatment.

Entities:  

Keywords:  Cannabinoid hyperemesis syndrome; Cannabis; Cyclic vomiting syndrome; Marijuana

Mesh:

Year:  2016        PMID: 28000146      PMCID: PMC5330965          DOI: 10.1007/s13181-016-0595-z

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  138 in total

Review 1.  The gastrointestinal pharmacology of cannabinoids: focus on motility.

Authors:  Raquel Abalo; Gema Vera; Ana Esther López-Pérez; María Martínez-Villaluenga; María Isabel Martín-Fontelles
Journal:  Pharmacology       Date:  2012-06-14       Impact factor: 2.547

Review 2.  Endocannabinoids and Mental Disorders.

Authors:  Tiziana Rubino; Erica Zamberletti; Daniela Parolaro
Journal:  Handb Exp Pharmacol       Date:  2015

Review 3.  Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic.

Authors:  Marvin Louis Roy Y Lu; Markus D Agito
Journal:  Cleve Clin J Med       Date:  2015-07       Impact factor: 2.321

4.  Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease.

Authors:  J Andrew Woods; Nicholas J D Wright; Jonathan Gee; Martin W Scobey
Journal:  Am J Ther       Date:  2016 Mar-Apr       Impact factor: 2.688

Review 5.  Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review.

Authors:  Robert A Beech; David R Sterrett; James Babiuk; Henry Fung
Journal:  J Oral Maxillofac Surg       Date:  2015-04-10       Impact factor: 1.895

Review 6.  The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.

Authors:  Federico Massa; Martin Storr; Beat Lutz
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

7.  Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.

Authors:  M Barann; G Molderings; M Brüss; H Bönisch; B W Urban; M Göthert
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 8.  Endocannabinoids in the gastrointestinal tract.

Authors:  Yunna Lee; Jeongbin Jo; Hae Young Chung; Charalabos Pothoulakis; Eunok Im
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-18       Impact factor: 4.052

9.  A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).

Authors:  Magdalena Kwiatkowska; Linda A Parker; Page Burton; Raphael Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

10.  Cannabinoid hyperemesis syndrome with extreme hydrophilia.

Authors:  Hilary A Enuh; Julia Chin; Jay Nfonoyim
Journal:  Int J Gen Med       Date:  2013-08-19
View more
  51 in total

1.  A case of cannabinoid hyperemesis syndrome highlighting related key paediatric issues.

Authors:  Cameron F Leveille; Robert M Issenman; April J Kam
Journal:  Paediatr Child Health       Date:  2020-06-15       Impact factor: 2.253

Review 2.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

3.  In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use".

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2017-04-05

4.  The Importance of Recognizing Cannabinoid Hyperemesis Syndrome from Synthetic Marijuana Use.

Authors:  Xibei Liu; Angela Villamagna; Ji Yoo
Journal:  J Med Toxicol       Date:  2017-03-28

5.  A 15-year-old girl with intractable vomiting.

Authors:  Deema Couchman; Megan E Harrison
Journal:  Paediatr Child Health       Date:  2018-01-29       Impact factor: 2.253

Review 6.  Medical cannabis for chronic pain: can it make a difference in pain management?

Authors:  Mari Kannan Maharajan; Yu Jing Yong; Hong Yang Yip; Sze Shee Woon; Kar Mon Yeap; Khai Yeng Yap; Shuen Chi Yip; Kai Xian Yap
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

7.  Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders.

Authors:  Stephen Lee-Cheong; Amrita Grewal; Lukas Hestvik; Reza Rafizadeh; Christian Schütz
Journal:  Can J Hosp Pharm       Date:  2020-10-01

8.  In Response to: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Joanne C Routsolias
Journal:  J Med Toxicol       Date:  2017-03-09

9. 

Authors:  G Michael Allan; Jamil Ramji; Danielle Perry; Joey Ton; Nathan P Beahm; Nicole Crisp; Beverly Dockrill; Ruth E Dubin; Ted Findlay; Jessica Kirkwood; Michael Fleming; Ken Makus; Xiaofu Zhu; Christina Korownyk; Michael R Kolber; James McCormack; Sharon Nickel; Guillermina Noël; Adrienne J Lindblad
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

Review 10.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.

Authors:  Ziva D Cooper; Rebecca M Craft
Journal:  Neuropsychopharmacology       Date:  2017-07-17       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.